The impact of age, disease severity, and BMI on bone health and growth in children and young people with Crohn's disease
Open Access
- 4 January 2024
- journal article
- research article
- Published by Wiley in JPGN Reports
- Vol. 5 (1) , 17-28
Abstract
The objective of this study was to explore the correlation between paediatric Crohn's disease (CD) characteristics, bone health and growth parameters at diagnosis and follow‐up. Retrospective data was collected for 47 children aged 4–16 who were newly diagnosed with CD between January 2018 and December 2019. Mean follow‐up time was 2.5 years. Eleven (24%) children had growth delay at diagnosis, which persisted in 4 (44%) of 9 recorded children at follow‐up. Of the 35 children tested, 20 (57%) had inadequate Vitamin D levels (<50 mmol/L) at diagnosis. Thirty‐seven (79%) children had a dual‐energy X‐ray absorptiometry scan at diagnosis, with 20 of them having at least 1 low Z‐score. Children with poorer bone mineral density and bone mineral concentration Z‐scores for age had a younger age at diagnosis (p = .042 and p = .021), more severe disease (p = .04 and p = .029) and a lower BMI (p < .001) at diagnosis. Children diagnosed with CD ≥11 years had a lower‐than‐expected height velocity (p < .0001 and p < .001). Multivariate regression analysis demonstrated an older age of diagnosis was a significant predictor of a lower height velocity at follow‐up. Disease severity and age of diagnosis are important CD‐related factors that influence bone health and growth. Vitamin D is an accessible component that if optimised can improve all three factors. Monitoring and optimising each aspect systematically has the potential to enable children to achieve their bone health and growth potentials. Growth failure occurs in up to 85% of children diagnosed with Crohn's disease and persists in up to 40%. Vitamin D plays a role in bone health (BH), growth, and intestinal inflammation. Chronic inflammation and undernutrition are key factors behind poor BH and growth failure. Children with poorer BH are younger, have more severe disease and a lower body mass index at diagnosis. An older age of diagnosis is an independent predictor of lower‐than‐expected height velocity in the future.Keywords
This publication has 66 references indexed in Scilit:
- Age-of-onset-dependent influence of NOD2 gene variants on disease behaviour and treatment in Crohn’s diseaseBMC Gastroenterology, 2013
- An update of the role of nutritional therapy in the management of Crohn’s diseaseJournal of Gastroenterology, 2012
- Vitamin D and BoneCurrent Osteoporosis Reports, 2012
- Skeletal Health of Children and Adolescents With Inflammatory Bowel DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2011
- Vitamin D Deficiency in Children with Inflammatory Bowel DiseaseDigestive Diseases and Sciences, 2011
- Risk Factors for Low Bone Mineral Density in Children and Adolescents with Inflammatory Bowel DiseaseDigestive Diseases and Sciences, 2008
- Linear Growth During Infliximab Therapy: Results of the REACH Multicenter StudyJournal of Pediatric Gastroenterology and Nutrition, 2006
- Calcium and 1α,25‐dihydroxyvitamin D3 target the TNF‐α pathway to suppress experimental inflammatory bowel diseaseEuropean Journal of Immunology, 2004
- Delayed Puberty Associated with Inflammatory Bowel DiseasePediatric Research, 2003
- RADIOGRAPHIC ATLAS OF SKELETAL DEVELOPMENT OF THE HAND AND WRISTThe American Journal of the Medical Sciences, 1959